These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1682865

  • 21. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
    Zhang X, Liu Y, Gilcrease MZ, Yuan XH, Clayman GL, Adler-Storthz K, Chen Z.
    Cancer; 2002 Oct 15; 95(8):1663-72. PubMed ID: 12365014
    [Abstract] [Full Text] [Related]

  • 22. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep 15; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 23. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.
    Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC.
    Oncogene; 1995 Oct 05; 11(7):1383-8. PubMed ID: 7478560
    [Abstract] [Full Text] [Related]

  • 24. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N, Isaacs JT.
    Cancer Res; 1990 Mar 01; 50(5):1449-54. PubMed ID: 2105838
    [Abstract] [Full Text] [Related]

  • 25. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J, Rajput AB, Lu H, Sanguin-Gendreau V, Zuo D, Papavasiliou V, Lavoie C, Turpin J, Cianflone K, Huntsman DG, Muller WJ.
    Mol Cell Biol; 2007 Sep 01; 27(18):6361-71. PubMed ID: 17636013
    [Abstract] [Full Text] [Related]

  • 26. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Hofmann M, Rudy W, Günthert U, Zimmer SG, Zawadzki V, Zöller M, Lichtner RB, Herrlich P, Ponta H.
    Cancer Res; 1993 Apr 01; 53(7):1516-21. PubMed ID: 8453616
    [Abstract] [Full Text] [Related]

  • 27. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG, Barbieri O, Piccini D, Noviello E, Zoppé M, Zucchi I, Frattini A, Villa A, Vezzoni P.
    Gene Ther; 1998 Mar 01; 5(3):388-93. PubMed ID: 9614559
    [Abstract] [Full Text] [Related]

  • 28. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 29. Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy.
    Chuang TC, Liu JY, Lin CT, Tang YT, Yeh MH, Chang SC, Li JW, Kao MC.
    FEBS Lett; 2007 Sep 18; 581(23):4443-9. PubMed ID: 17719580
    [Abstract] [Full Text] [Related]

  • 30. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
    Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R.
    Cancer Res; 1993 Nov 01; 53(21):5251-61. PubMed ID: 8106145
    [Abstract] [Full Text] [Related]

  • 31. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC.
    Oncogene; 1997 Feb 06; 14(5):561-8. PubMed ID: 9053854
    [Abstract] [Full Text] [Related]

  • 32. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
    Wada T, Myers JN, Kokai Y, Brown VI, Hamuro J, LeVea CM, Greene MI.
    Oncogene; 1990 Apr 06; 5(4):489-95. PubMed ID: 1970151
    [Abstract] [Full Text] [Related]

  • 33. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
    Glondu M, Liaudet-Coopman E, Derocq D, Platet N, Rochefort H, Garcia M.
    Oncogene; 2002 Aug 01; 21(33):5127-34. PubMed ID: 12140763
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.
    Qian X, O'Rourke DM, Zhao H, Greene MI.
    Oncogene; 1996 Nov 21; 13(10):2149-57. PubMed ID: 8950982
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
    Yu D, Liu B, Tan M, Li J, Wang SS, Hung MC.
    Oncogene; 1996 Sep 19; 13(6):1359-65. PubMed ID: 8808711
    [Abstract] [Full Text] [Related]

  • 36. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb 19; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 37. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K.
    J Cell Biochem; 1991 Jan 19; 45(1):69-81. PubMed ID: 1706346
    [Abstract] [Full Text] [Related]

  • 38. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
    Masuelli L, Focaccetti C, Cereda V, Lista F, Vitolo D, Trono P, Gallo P, Amici A, Monaci P, Mattei M, Modesti M, Forni G, Kraus MH, Muraro R, Modesti A, Bei R.
    Int J Oncol; 2007 Feb 19; 30(2):381-92. PubMed ID: 17203220
    [Abstract] [Full Text] [Related]

  • 39. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products.
    Chen L, Zhang W, Fregien N, Pierce M.
    Oncogene; 1998 Oct 22; 17(16):2087-93. PubMed ID: 9798679
    [Abstract] [Full Text] [Related]

  • 40. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD, Allen HL, Kraynak AR, Bradley MO.
    Oncogene; 1988 Feb 22; 2(2):141-7. PubMed ID: 3285293
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.